PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Imipramine hydrochloride - Overactive bladder (adults)
PAD Profile : Imipramine hydrochloride - Overactive bladder (adults)
Keywords :
OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, overactive bladder, urinary urgency
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Darifenacin hydrobromide
- Flavoxate hydrochloride
- Oxybutynin
- Propiverine hydrochloride
- Solifenacin
- Mirabegron
- Fesoterodine fumarate
- Trospium chloride
- Tolterodine
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 February 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Imipramine is not recommended for treating overactive bladder in line with NICE NG123 - guidance can be found below
Associated BNF Codes
07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.02. Drugs for urinary frequency enuresis and incontinence